Google Alert - "LSD1 inhibitor" OR "sickle cell disease" · Scour

Beam Therapeutics Announces Publication of BEACON Phase 1/2 Data for risto-cel in ...

Saudi Hospital KFSH Successfully Implements Gene Therapy for Sickle Cell Disease

Casey Cares Foundation

Saudi Hospital KFSH Successfully Implements Gene Therapy for Sickle Cell Disease

7 Sweeping New Florida Laws That Are Taking Effect In 2026

Gene Editing Therapy Succeeds in Severe Sickle Cell

Beam Therapeutics publishes sickle cell therapy trial data - Investing.com South Africa

Base Editing of HBG1 and HBG2 Promoters for Sickle Cell Disease

Agios Pharmaceuticals (AGIO) Moves 14.3% Higher: Will This Strength Last?

Beam Therapeutics Announces Publication of BEACON Phase 1/2 Data for risto-cel in ...

Why Is BEAM Stock Edging Higher After Hours Today?

Cleveland Clinic Appoints Beri Ridgeway, M.D., as President of Cleveland Clinic London

Base-Editing Gene Therapy Shows Promise in Sickle Cell Disease

Beam Therapeutics publishes sickle cell therapy trial data

Dr. Joseph Ricotta Surpasses 500 TCAR Procedures, Reinforcing Leadership in Stroke Prevention

From Pain to Purpose: Local woman transformed by groundbreaking Cleveland Clinic sickle cell trial

Beam Therapeutics Announces Publication of BEACON Phase 1/2 Data for risto-cel in ...

Beam Therapeutics NEJM publishes Phase 1/2 risto-cel data

CRISPR-Cas12a Gene Editing of HBG1 and HBG2 Promoters to Treat Sickle Cell Disease

Gene Editing Therapy Shows Success Against Severe Sickle Cell Disease

Log in to enable infinite scrolling